Paper33567945
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings.
Pallavicini C and 10 others. J Psychopharmacol, 2021. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings. Papers, record 33567945. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33567945
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Consciousness Disorders | Major topic |
| Electroencephalography | Major topic |
| Mysticism | Major topic |
| N,N-Dimethyltryptamine | Major topic |
| Personality Inventory | Major topic |
| Relaxation Therapy | Major topic |
| Administration, Inhalation | |
| Adult | |
| Biological Availability | |
| Drug Monitoring | |
| Female | |
| Hallucinogens | |
| Humans | |
| Male | |
| Outcome Assessment, Health Care | |
| Psychometrics | |
| Self Concept | |
| Self Report | |
| Wireless Technology |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42891832 | Beyond psychedelic exceptionalism: how people combine meditation with psychoactive substances, and how this relates to well-being. | Psychopharmacology (Berl) | 2026 | https://conductscience.org/library/papers/42891832 | PubMed |
| 42559191 | Longitudinal neural and psychological changes following psilocybin under compassion imagery priming. | Front Hum Neurosci | 2026 | https://conductscience.org/library/papers/42559191 | PubMed |
| 42343098 | Multi-metric evaluations of acute psychedelic effects on fMRI brain entropy. | Nat Commun | 2026 | https://conductscience.org/library/papers/42343098 | PubMed |
| 41684524 | High hopes? Precision psychedelic addiction medicine. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/41684524 | PubMed |
| 41561362 | Investigating the role of beta and gamma tACS in visual processing and conscious perception. | Neurosci Conscious | 2026 | https://conductscience.org/library/papers/41561362 | PubMed |
| 41458361 | Psilocybin-induced modulation of visual salience processing. | Neurosci Conscious | 2025 | https://conductscience.org/library/papers/41458361 | PubMed |
| 41419333 | Neurochemical and Neurophysiological Effects of Intravenous Administration of N,N-Dimethyltryptamine in Rats. | J Neurosci | 2026 | https://conductscience.org/library/papers/41419333 | PubMed |
| 41285580 | DMT-Induced Shifts in Criticality Correlate with Self-Dissolution. | J Neurosci | 2026 | https://conductscience.org/library/papers/41285580 | PubMed |
| 41219657 | Cognitive control as a transdiagnostic mechanism of action in psychedelic effects. | Cogn Affect Behav Neurosci | 2026 | https://conductscience.org/library/papers/41219657 | PubMed |
| 40656118 | Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms. | Neurosci Appl | 2024 | https://conductscience.org/library/papers/40656118 | PubMed |
| 40654586 | An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers. | Neurosci Appl | 2025 | https://conductscience.org/library/papers/40654586 | PubMed |
| 40260121 | Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness. | Neurosci Conscious | 2025 | https://conductscience.org/library/papers/40260121 | PubMed |
| 40251353 | Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience. | Commun Biol | 2025 | https://conductscience.org/library/papers/40251353 | PubMed |
| 40210737 | The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity. | Psychopharmacology (Berl) | 2025 | https://conductscience.org/library/papers/40210737 | PubMed |
| 40110076 | An encounter with death: a comparative thematic and content analysis of naturalistic DMT experiences and the near-death experience. | Front Psychol | 2025 | https://conductscience.org/library/papers/40110076 | PubMed |
| 40069397 | Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT). | Commun Biol | 2025 | https://conductscience.org/library/papers/40069397 | PubMed |
| 39937729 | Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors. | PLoS One | 2025 | https://conductscience.org/library/papers/39937729 | PubMed |
| 39539622 | Increased functional connectivity between brain regions involved in social cognition, emotion and affective-value in psychedelic states induced by N,N-Dimethyltryptamine (DMT). | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39539622 | PubMed |
| 39301949 | Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being. | J Psychopharmacol | 2024 | https://conductscience.org/library/papers/39301949 | PubMed |
| 39254764 | Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors. | Cell Mol Life Sci | 2024 | https://conductscience.org/library/papers/39254764 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33567945
GET https://conductscience.org/api/papers/v1/33567945/cited_by?page=2